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A B S T R A C T
Background: People at early stages of multiple sclerosis have subtle balance problems that may affect gait sta-
bility. However, differences in methods of determining stability such as sensor type and placements, may lead to
different results and affect their interpretation when comparing to controls and other studies.
Questions: Do people with multiple sclerosis (PwMS) exhibit lower gait stability? Do location and type of data
used to calculate stability metrics affect comparisons?
Methods: 30 PwMS with no walking impairments as clinically measured and 15 healthy controls walked on a
treadmill at 1.2 ms−1 while 3D acceleration data was obtained from sacrum, shoulder and cervical markers and
from an accelerometer placed at the sacrum. The local divergence exponent was calculated for the four data
sources. An ANOVA with group (multiple sclerosis and control) and data source as main factors was used to
determine the effect of disease, data source and their interaction on stability metrics.
Results: PwMS walked with significantly less stability according to all sensors (no interaction). A significant
effect of data source on stability was also found, indicating that the local divergence exponent derived from
sacrum accelerometer was lower than that derived from the other 3 sensor locations.
Significance: PwMS with no evident gait impairments are less stable than healthy controls when walking on a
treadmill. Although different data sources can be used to determine MS-related stability deterioration, a con-
sensus about location and data source is needed. The local divergence exponent can be a useful measure of
progression of gait instability at early stages of MS.
1. Introduction
Multiple sclerosis (MS) is the most common inflammatory demye-
linating disease of the central nervous system causing disability in
young adults [1]. Walking impairment is a frequent and disabling
consequence and is given the highest priority by people with MS
(PwMS) [2]. Spatiotemporal measures of gait have revealed that PwMS
use strategies that may improve their stability, i.e. taking short steps [3]
even when they have no overt disability [4]. These compensations are
possibly employed to decrease instability that may lead to an increased
risk of falling [5].
Since current clinical measures of disability have been shown to be
insensitive to gait subtle changes, new markers of ambulatory function
in PwMS have been recommended [6,7]. The local divergence exponent
(LDE), has been proposed as a gait stability measure in neurological
populations including PwMS [6,8,9]. However, there are methodolo-
gical concerns about the LDE’s validity derived from different sensor
locations and using a different number of strides [10,11]. A good sta-
bility metric can be of high relevance as it can inform clinicians about
disease progression and/or interventions effectiveness; especially at MS
early stages when these interventions may be more effective.
The LDE quantifies the exponential rate of divergence and reflects
the ability of the motor control system to cope with small perturbations
elicited at each step [11]. Since the LDE has been derived using dif-
ferent methods, such as different forms of sensors, sensor locations and
type of data (e.g. velocity or acceleration) so that there is still no
general consensus about its clinical implementation [10]. In this study,
we aimed to determine the effects different data sources on gait stabi-
lity (LDE short-term) in PwMS during treadmill walking.
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Thirty people with relapsing-remitting MS (PwMS) were recruited.
Inclusion criteria were: a)< 15 years since onset; b)aged > 18 years;
c)EDSS<4.0 (ambulation = 0). Exclusion criteria included: a)Other
neurological conditions; b)Cardiovascular disease; c)Orthopaedic con-
ditions. Healthy controls (HC, n = 15) were recruited if they had no
neurological or orthopaedic conditions and were > 18 years. All de-
mographics and clinical data are presented in Table 1. This study was
approved by the Melbourne Health Ethics Committee (2015.144). All
participants provided signed informed consent.
2.2. Setup
Reflective markers were placed on body landmarks following the
Plug-in-Gait model. An 8-camera Vicon system (Oxford, UK) was used
to collect kinematics at 200 Hz. A wireless inertial measurement unit
(IMU) (Cometa, Milano, Italy) collected 3D accelerations (1000 Hz)
from a sensor placed at the sacrum. Nexus 2 (Vicon, Oxford, UK) was
used to record all data.
2.3. Assessments
Participants walked barefoot on a Biodex-RTM600 (Shirley, NY,
USA) treadmill at 1.2 ms−1 without holding the rails for 5 min to obtain
at least 150 gait cycles. No participant reported fatigue after walking.
2.4. Data processing
All data were processed using Matlab R2019a (Natwick, MA, USA).
The LDEwas calculated for the 3D accelerations of 3 markers: mid-
shoulder, average position between shoulder markers; sacrum, average
position between posterior superior iliac spine (PSIS) markers and se-
venth cervical marker (cervical). Acceleration was also obtained from
an IMU located between PSISs (sacruma). Data from 150strides was
used for all participants), which were time-normalized to 150 × 100
samples. Reconstructed state-spaces were calculated using 3 embedded
dimensions (9 dimensions per state-space) with a time delay of 10
samples. The 0 to 0.5 stride LDE (log(divergence)/stride), or short-term
LDE, was calculated from the divergence curve for markers’ accelera-
tion and IMU data [12]. The short-term LDE reflects the ability of the
motor control system to cope with step-to-step perturbations [11].
Table 1
Participants demographics and Expanded Disability Status Scale (EDSS) clinical
scores for people with multiple sclerosis (PwMS) and spatiotemporal measures
of gait for both groups. IDS: initial double support; SS: single stance; SDS:
second double support.
PwMS (n = 30) HC (n = 15)
mean sd mean sd p
Age (years) 42.5 ±9.2 36.8 ±7.0 0.03
Height (cm) 167.7 ±6.5 170.8 ±12.6 0.28
Weight (kg) 70.6 ±12.0 69.8 ±14.7 0.86
Sex (f/m) 25/5 – 9/6 –
EDSS 1.2 ±0.9 – –
EDSS range [0–2.5]
Speed (m/s) 1.2 – 1.2 – –
Cadence (steps/min) 114.7 ±5.33 112.82 ±5.82 0.29
Step length (cm) 62.87 ±3.01 63.93 ±3.31 0.35
Stride length (cm) 125.75 ±5.89 127.87 ±6.45 0.28
Step width (cm) 9.44 ±3.29 8.27 ±2.89 0.36
Stance% 70.24 ±7.90 73.4 ±8.99 0.21
IDS% 20.39 ±7.94 23.39 ±8.99 0.25
SS% 29.33 ±8.25 26.6 ±8.99 0.34
SDS% 20.52 ±8.04 23.4 ±8.99 0.29
Swing% 29.76 ±7.90 26.6 ±8.99 0.21
Fig. 1. Averaged divergence curves for people
with MS (PwMS; dotted red line) and healthy
controls (HC; dotted blue line) for the four
acceleration data sources (sacrum, sacruma,
mid-shoulder and cervical). The short-term
local divergence exponents (LDEs ; 0-0.5
stride) are also presented for PwMS (con-
tinuous red line) and for HC (continuous blue
line). (For interpretation of the references to
colour in this figure legend, the reader is re-
ferred to the web version of this article).
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2.5. Statistical analysis
Normality of data was confirmed using Skewness and Kurtosis. An
ANOVA with group as between factor (PwMS and HC) and data source
(sacrum, mid-shoulder, cervical and sacruma) as within factor was used
to determine disease, sensor location and their interaction effect on
LDEs. A post-hoc analysis was used to determine where significant
differences occurred (Bonferroni adjustments). A separate ANOVA was
used to determine group differences for spatiotemporal measures. For
all analyses significance was set p<0.05.
3. Results
No significant between groups difference for any of the spatio-
temporal measures was found (Table 1). Fig. 1 shows average diver-
gence curves and LDEs for all data sources and both groups. PwMS
walked significantly less stable than HC as shown by the significant
main effect of disease (p<0.01) (Table 2). A significant main effect of
data source was also found (p<0.01), yet no significant interaction(p
= 0.24). Post-hoc analysis on the LDE obtained from different data
sources revealed that LDE calculated from the accelerometer placed on
the sacrum was significantly lower than LDE calculated from the other
3 data sources (p<0.04).
4. Discussion
The aim of this study was to compare gait stability (expressed as the
LDE) between PwMS with no gait impairments and healthy controls
when walking on a treadmill at a fixed speed using different sensor
locations and data sources. Overall, the results indicate that PwMS
walked less stable than HC and that LDE calculated from accelerometer
data may underestimate instability compared to markers-derived LDE.
On average, LDE was 18±1.7 % higher in PwMS using markers ac-
celeration yet 7 % when using sacrum accelerometer. Although it it is
difficult to pinpoint a cause for this difference, it may be due to ac-
celerometer’s sensitivity, positioning, movement artifacts and/or
sample rate [10]. This highlights the need for consistency within a
study but also the need for a consensus about these issues in future
research [10].
Previous studies using accelerometers to analyse PwMS’s stability
have shown that the LDE: 1) can be used in clinical settings [8,9], 2) is
greater in PwMS than healthy controls [9], 3) improves after 3-weeks
rehabilitation [8] and is greater in PwMS with falls history [13].
However, these studies assessed a relatively heterogeneous MS popu-
lations with EDSS scores ranging from 4.2 [6] to 5.1 [8]. PwMS with
EDSS scores> 3.5 already exhibit some degree of walking disability.
Also, these studies recorded acceleration over 30 s trials (∼30 m
walkway) [9] or between 17–60 strides [8,13], which is less than the
150 strides recommended for LDE’s statistical precision [11]. In sum-
mary, patients homogeneity in terms of disability, and number of
strides are of high relevance when trying to determine subtle gait
changes in PwMS at early stages when gait deterioration is no evident
to clinical examination.
Although treadmill walking is the most adequate alternative for
large datasets acquisition, it is also known that it may impose a less
challenging condition compared to overground walking [14]. Further-
more, access to a treadmill may be limited in some clinical settings. An
alternative to collect large datasets may be using walking acceleration
(e.g. at the sacrum as in this study) over several laps in a long corridor
from which other clinical measures, e.g.6-minutes and 25-feet walking
tests, can also be obtained [15].
Although all data sources showed greater LDE in PwMS than con-
trols, the use of accelerometers is more implementable than motion
tracking in clinical settings [6,8,13]. Although LDE responsiveness to
the effects of rehabilitation has been shown in PwMS with evident gait
impairments [8], its use as a clinical outcome measure is yet to be
determined for physiotherapy and pharmacological interventions at MS
early stages. Further studies should also explore the underlying me-
chanisms of gait stabillity deterioration in PwMS that may help tar-
geting interventions.
5. Conclusion
PwMS with no evident gait impairments are less stable than healthy
controls when walking on a treadmill. Different data sources can be
used to determine MS-related stability deterioration. TheLDE can be a
useful measure of gait disability progression at MS early stages.
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